Botulism toxin: use in disorders of the temporomandibular joint.
Chang
Heera
H
Columbia University School of Dental and Oral Surgery, Division of Oral and Maxillofacial Surgery, USA. hkc3@columbia.edu
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002012:Bruxism / Q000188:drug therapy; D004421:Dystonia / Q000188:drug therapy; D005157:Facial Pain / Q000188:drug therapy; D006801:Humans; D006984:Hypertrophy / Q000188:drug therapy; D008410:Masticatory Muscles / Q000503:physiopathology; D009128:Muscle Spasticity / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A